Genetics of diabetic complications: Nephropathy;Génétique des complications du diabète: Néphropathie

Annales d'Endocrinologie

Volumn 65, Issue 1 SUPPL., 2004, Pages

  Jeunemaitre, X ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Diabetes mellitus; Diabetic nephropathy; Gene polymorphisms; Genetics; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; ETHNIC DIFFERENCE; FAMILIAL DISEASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; DIABETES MELLITUS; DIABETIC ANGIOPATHY; GENETICS; METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 2942753864     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Friedlander MA, Hricik DE. Optimizing end-stage-renal disease therapy for the patients with diabetes mellitus. Semin Nephrol 1997; 17: 331-45.
2. Halimi S, Zmirou D, Benhamou PY et al. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French Territories. A second national survey six years apart (UREMIDIAB 2 Study). Diabetes Metab 1999; 25: 507-12.
3. Renal Data System. USRDS 2000 annual data report. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases. 2001. (www.usdrs.org/adr_2000.htm)
4. Cordonnier D, Bayle F, Benhamou PY et al. Future trends of management of renal failure in diabetics. Kidney Int 1993; 41: S8-S13.
5. Andersen AR, Christiansen JS, Andersen JK, Kreine S, Deckert S. Diabetic nephropathy in type 1 (insulin-dependent) diabetes, an epidemiological study. Diabetologia 1983; 25: 496-501.
6. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-88.
7. Parving HH, Gall MA, Skott P et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1993; 41: 758-62.
8. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998, 352: 213-219.
9. Borch-Johnsen, Nissen H, Henriksen E et al. The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabet Med 1987; 4: 201-10.
10. Stephenson J, Fuller JH on behalf of the EURODIAB-IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB-IDDM Complications Study. Diabetologia 1994; 37: 278-85.
11. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-68.
12. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreimer S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 1987; 36: 205-9.
13. Krolewski AS, Narram JH, Christlieb AR, Busick EJ, Kuhn CR. The changing natural history of nephropathy in type 1 diabetes. Am J Med 1985; 78: 785-94.
14. Hovind P, Tarnow L, Rossing K et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003; 26: 1258-64.
15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977-86.
16. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
17. Baba T, Neugebauer S, Watanabe T. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention. Drugs 1997; 54: 197-234.
18. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications of type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-13.
19. Adler AI, Stratton IM, Neil AW et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J 2000; 321: 412-9.
20. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999; 42: 263-85.
21. Remuzzi G, Schieppati A, Ruggenenti P. Nephropathy in patients with type 2 diabetes. New Engl J Med 2002; 346: 1145-51.
22. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases. A meta-analysis. Ann Intern Med 1996; 124: 627-32.
23. Consensus Development Conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1994; 17: 1357-61.
24. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. New Engl J Med 1989; 320: 1161-5.
25. Earle K, Walker J, Hill C, Viberti GC. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. New Engl J Med 1992; 326: 673-7.
26. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 1987; 295: 515-7
27. Dogra G, Watts GF. Genes and diabetic nephropathy: what have we learnt so far? Pract Diab Int 2000; 17: 84-90.
28. Marre M, Bernadet P, Gallois Y et al. Relationships between angiotensin 1 converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-8.
29. Staessen JA, Wang JG, Ginocchio G et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15: 1579-92.
30. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin 1-converting enzyme gene. Diabetes 1994; 43: 690-5.
31. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Br Med J 1994; 309: 1608-12.
32. Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int, 1995, 47: 1176-1181 (erratum in Kidney Int, 1995, 48: 915).
33. Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int, 1995, 47: 1176-1181 (erratum in Kidney Int, 1995, 48: 915).
34. Tarnow L, Cambien F, Rossing P et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-94.
35. Marre M, Jeunemaitre X, Gallois R et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Génétique de la Néphropathie Diabétique (GENEDIAB) study group. J Clin Invest 1997; 99: 1585-95.
36. Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ. UK Prospective Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48: 1907-11.
37. Doi Y, Yoshizumi H, Yoshinari M et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97-102.
38. Ohno T, Kawasu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996; 45: 218-22.
39. Schmidt S, Ritz E. Angiotensin 1 converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. Nephrol Dial Transplant 1997; 12 (Suppl.2): 37-41.
40. Grzeszczak W, Zychma MJ, Lacka B, Zukowska-Szczechowska E. Angiotensin 1-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin-dependent diabetes mellitus. J Am Soc Nephrol 1998; 9: 1664-9.
41. Feng Y, Niu T, Xu X et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002; 51: 1986-8.
42. Hadjadj S, Belloum R, Bouhanick B et al. Pronostic value of angiotensin-1 converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 2001; 12: 541-9.
43. Schunkert H, Hense HW, Gimenez-Roqueplo AP et al. The angiotensinogen T235 variant and the use of antihypertensive drugs: a population-based cohort. Hypertension 1997; 29: 628-33.
44. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, Zinman B. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997; 29: 1073-7.
45. Doria A, Onuma T, Gearin G, Freire MB, Warram JH, Krolewski AS. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes mellitus. Hypertension 1996; 27: 1134-9.
46. Tarnow L, Cambien F, Rossing P et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996; 45: 367-9.
47. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 1998; 31: 627-31.
48. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996; 45: 1204-8.
49. Baughman KL. B-type natriuretic peptide: a window to the heart. New Engl J Med, 2002; 347: 158-159.
50. Roussel R, Tregouet DA, Hadjadj S, Jeunemaitre X, Marre M. Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. Diabetes 2004, in press.